The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS).

Schlander, M; Garattini, S; Holm, S; Kolominsky-Rabas, P L; Nord, E; Persson, U; Postma, M J; Richardson, J; Simoens, S; de Sola-Morales, O; Tolley, K; Toumi, M

Schlander, M; Garattini, S; Holm, S; Kolominsky-Rabas, P L; Nord, E; Persson, U; Postma, M J; Richardson, J; Simoens, S; de Sola-Morales, O; Tolley, K; Toumi, M.

Afiliación

Schlander M; Institute for Innovation & Valuation in Health Care (InnoVal-HC), Wiesbaden, Germany.
Garattini S; Mario Negri Institute for Pharmacological Research, Milano, Italy.
Holm S; University of Manchester, Manchester, UK.
Kolominsky-Rabas PL; University of Erlangen, Erlangen, Germany.
Nord E; Norwegian Institute of Public Health, Oslo, Norway.
Persson U; The Swedish Institute for Health Economics (IHE), Lund, Sweden.
Postma MJ; University of Groningen, Groningen, The Netherlands.
Richardson J; Monash University, Clayton, Victoria, Australia.
Simoens S; KU Leuven, Leuven, Belgium.
de Sola-Morales O; Sabirmedical, Barcelona, Spain.
Tolley K; Tolley Health Economics Ltd., Buxton, Derbyshire, UK.
Toumi M; University Claude Bernard Lyon 1, Lyon, France.

Value Health ; 17(7): A324, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27200532

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google